TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06052007

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LC-Based Debriefing
Description: LC-based debriefing encourages reflection by allowing learners to identify and explore topics of particular interest. The model is defined as a structured post-event LC, which is useful for improving competence, professional development, and clinical judgment among intensive care unit and trauma nurses. The model is useful not only for one recipient by allowing reflection on positive and negative experiences but also for the whole group by allowing them to make connections to their own practice that day or to previous experiences, supporting teamwork. It also helps them understand what good practice is by doing their own self-assessment with peers' benchmarking.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 3D Model-Based Debriefing
Description: The model has three parts: defusing, discovering, and deepening. The experiential learning theory on which this model is based facilitates learning goals. This model allows its participants to create new mental models for future practice, develop critical thinking skills, and identify knowledge gaps. In the model, a debriefing session starts with preliminary information and ends with a summary of what has been learned. Participants' gaps in understanding and learning are identified, and how they can apply their learnings to practice is discussed.
Study: NCT03637387

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB074
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.
Study: NCT05871554

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mind-OP+
Description: Mind-OP is an online program designed to cultivate mindfulness and self-compassion developed by Beshai and his team. Mind-OP is self-guided, with four modules administered at a pace of one module per week (four weeks total). The version used for this study, Mind-OP+, is five weeks total, containing an extra module focused on connectedness.~The modules contain psychoeducational videos, guided audio meditations, goal-setting and motivational interviewing inspired exercises. Participants also have opportunities to engage with meditations and other exercises embedded within each module.~The first module (Week 1) introduces the concept of mindfulness. The second module (Week 2) focuses on attention to bodily sensations and thoughts. The third module (Week 3) introduces the concept of self-compassion. The fourth module (Week 4) focuses on the self-kindness component of self-compassion. The fifth module (Week 5) focuses on the concept of connectedness.
Study: NCT05707793

Intervention type: OTHER
Intervention: Evaluating sexual function, quality of life and pelvic floor muscle strength, as well as thickness and force (strength) of voluntary contractions of the core muscles
Description: Evaluation through Vaginal Laxity Questionnaire, Female Sexual Function Index, Short-Form 36 Health Survey, modified Oxford grading scale and ultrasound imaging

Intervention type: OTHER
Intervention: Evaluating sexual function, quality of life and pelvic floor muscle strength, as well as thickness and force (strength) of voluntary contractions of the core muscles
Description: Evaluation through Vaginal Laxity Questionnaire, Female Sexual Function Index, Short-Form 36 Health Survey, modified Oxford grading scale and ultrasound imaging
Study: NCT05250791

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine hydrochloride 2% for injection
Description: An intravenous bolus of 2% lidocaine will be administered following the induction of anaesthesia at 1.5mg/kg ideal body weight over 20 minutes followed by intravenous infusion of 1.5 mg/kg/hour ideal body weight with a maximum rate of 120mg/hour for 24 hours.
Study: NCT05024058

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ligelizumab
Description: Ligelizumab treated groups and arms

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ligelizumab
Description: Ligelizumab treated groups and arms

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ligelizumab
Description: Ligelizumab treated groups and arms

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ligelizumab
Description: Ligelizumab treated groups and arms

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ligelizumab
Description: Ligelizumab treated groups and arms

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo treated groups and arms

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo treated groups and arms

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo treated groups and arms
Study: NCT05916534

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WeCAB Intervention
Description: The WeCAB intervention will use a dedicated WeCAB community health worker who will administer a social determinants of health (SDOH) tool and use digital care navigation to monitor closed loop referrals.
Study: NCT05043493

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Injection in the intraarticular space of glenohumeral joint
Description: U/S guided injection of platelet rich plasma (PRP) or normal saline (NS)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Injection in the intraarticular space of glenohumeral joint
Description: U/S guided injection of platelet rich plasma (PRP) or normal saline (NS)
Study: NCT05345431

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: endovascular denervation
Description: Treating with EDN at the site of the iliac artery distal to the superficial femoral artery proximal before balloon dilation or stent implantation

Intervention type: DEVICE
Group type: OTHER
Intervention: PTA
Description: Treating with balloon dilation or stent implantation
Study: NCT04730739

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FastFrame External Fixation System - Knee Spanning or Damage Control Kit
Description: The FastFrame External Fixation Systems - Knee Spanning Kit and Damage Control Kit are single-use external fixators that are sterile packed with all required components for convenience of the end user.
Study: NCT05250791

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% sterile Sodium Chloride solution for injection
Description: Administered as lidocaine
Study: NCT04064346

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lixivaptan
Description: Oral vasopressin V2 receptor antagonist

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT05338203

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tandem breastfeedıng
Description: mother mılk wıll collected from mothers and they wıll be analyzed in laboratuar.
Study: NCT04930354

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ECP-1014
Description: Patients will be selected who (1) have failed all standard of care therapy (relapsed/refractory) or (2) have relapsed and are not a candidate for an available standard of care therapy as assessed by the investigator (such as, but not limited to, colorectal cancer (CRC), Non-Small Cell Lung Cancer (NSCLC), head and neck, etc.) with COX-2 overexpression, ultimately resulting in elevated production of prostaglandin E2 (PGE2).
Study: NCT06208059

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: manual acupuncture
Description: In manual acupuncture, the scalp motor area on the lesion side will be needled and left in place for 30 minutes after obtaining qi. During the needle retention, the needles will be twisted intermittently for 2 minutes twice, at a frequency of approximately 200 r/min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: In electroacupuncture, the scalp motor area will be needled, and after obtaining qi, the treatment will involve applying electroacupuncture stimulation using a continuous wave with a frequency of 2 Hz. The intensity of the stimulation will be adjusted based on the patient's tolerance, and each treatment session will last for 30 minutes.
Study: NCT05551494

Intervention type: DIAGNOSTIC_TEST
Intervention: Urinary sample
Description: At study entry, we will collect urinary samples from women. Participants will be asked with an interview on demographic and lifestyle characteristics, health-related behaviours, the existence and duration of infertility, medical history, and history of hormonal or surgical treatments for endometriosis. Pain symptoms will be evaluated through a 10 cm long one-dimensional visual-analogue scale (VAS).~In addition, women will be asked to report about their habits about consumption of plastic

Intervention type: DIAGNOSTIC_TEST
Intervention: Urinary sample
Description: At study entry, we will collect urinary samples from women. Participants will be asked with an interview on demographic and lifestyle characteristics, health-related behaviours, the existence and duration of infertility, medical history, and history of hormonal or surgical treatments for endometriosis. Pain symptoms will be evaluated through a 10 cm long one-dimensional visual-analogue scale (VAS).~In addition, women will be asked to report about their habits about consumption of plastic
Study: NCT06423144

Intervention type: PROCEDURE
Intervention: TACE/HAIC
Description: TACE/HAIC were performed within 1 month prior/after the first PD-1/PD-L 1 inhibitor/antiangiogenic drug treatment;

Intervention type: DRUG
Intervention: PD-1/PD-L1 inhibits and anti-angiogenic agents
Description: Agents were administrated based on the instructions recommended

Intervention type: DRUG
Intervention: PD-1/PD-L1 inhibits and anti-angiogenic agents
Description: Agents were administrated based on the instructions recommended
Study: NCT06160973

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Feed the Household
Description: Medically tailored meals will be provided for the enrolled individual, with additional meals provided as needed for others living the same household

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Feed the Household
Description: Medically tailored meals will be provided for the enrolled individual, with additional meals provided as needed for others living the same household

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dedicated Driver
Description: Medically tailored meals will be delivered each week by a driver who is an employee of Community Servings

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dedicated Driver
Description: Medically tailored meals will be delivered each week by a driver who is an employee of Community Servings

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Feed the Individual
Description: Medically tailored meals will be provided for the enrolled individual

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Feed the Individual
Description: Medically tailored meals will be provided for the enrolled individual

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Commercial Shipper
Description: Meals will be delivered by a commercial shipping organization

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Commercial Shipper
Description: Meals will be delivered by a commercial shipping organization
Study: NCT05302154

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Distraction by dentist
Description: Basic behavior orientation techniques (tell-show-do) is applied by the dentist during the treatment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Distraction by cartoon movie
Description: Children watch cartoons on a screen mounted dental unit during the treatment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Distraction by virtual reality glasses
Description: During the treatment visual and auditory stimuli provide information about treatment to the patient with the help of avatars (characters) and environmental elements placed within the VRG application. In a vivid dentist room, the explanatory introduction part takes place while the movies are watched in a fairy world or a futuristic world to separate the user from the actual location and context. The application was designed to function in such a way as not to require outside intervention. From start to finish, the application interacts with the user through gaze selection and head tracking mechanisms. The avatar characters provide information related to the dental treatment in a joyful manner. Gamification elements such as gaining stars and collecting rewards have been used to keep the patient engaged. Motion blur feature ensures the patient to keep head still as sudden movements are dangerous and undesired by the dentist during the treatment.
Study: NCT05698147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Selinexor dose escalation: 60,80,100mg respectively on day 1,8,15,22 for 28 days cycles, and dose expansion at the RP2D of Selinexor.~PR patients after induction treatment will continue ATG-010 maintenance up to 1 year or until disease progression, intolerable toxicity, death.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab 375 mg/m2 intravenous infusion d1, every 28 days for 6 cycles during combination induction treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: high-dose Methotrexate 3.5 g/m2 intravenous infusion d1, every 28 days for 6 cycles during combination induction treatment.
Study: NCT05608044

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: An anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: An anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: An anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: An anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Balstilimab
Description: An anti-programmed death (ligand) 1 \[PD-(L)1\] monoclonal antibody.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Balstilimab
Description: An anti-programmed death (ligand) 1 \[PD-(L)1\] monoclonal antibody.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Regorafenib or trifluridine and tipiracil.
Study: NCT06372015

Intervention type: OTHER
Intervention: Nutritional Approach
Description: Nutritional Approach

Intervention type: OTHER
Intervention: Surgery Approach
Description: Bariatric surgery
Study: NCT04852458

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) hydrocortisone
Description: Participants (20) will be given IV hydrocortisone within 6-12 hours of the traumatic event.~90 - 150 mg. of intravenous hydrocortisone dosing regimen based on participant weight: 90mg will be administrated to participants weighing 45-59kg. 100mg will be administrated to participants weighing 60-69kg. 120mg will be administrated to participants weighing 70-89kg. 140mg will be administrated to participants weighing 90-99kg. 150mg will be administrated to participants weighing 100-120kg.
Study: NCT06523504

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DIMS
Description: wear DIMS ,and use placebo,once nightly, both eye

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The 0.02% ATP Group
Description: wear SP, and use 0.02%ATP eye drops, once nightly, both eye

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The 0.04% ATP Group
Description: wear SP, and use 0.04%ATP eye drops, once nightly, both eye

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 0.02%ATP+DIMS
Description: wear DIMS, and use 0.02%ATP eye drops, once nightly, both eye

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 0.04%ATP+DIMS
Description: wear DIMS, and use 0.04%ATP eye drops, once nightly, both eye
Study: NCT06391736

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: GC301
Description: GC301, is an adeno-associated virus 9 (AAV9) vector delivering a functional copy of the human GAA gene

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: GC301
Description: GC301, is an adeno-associated virus 9 (AAV9) vector delivering a functional copy of the human GAA gene
Study: NCT05812976

Intervention type: OTHER
Intervention: Pulmonary Index of Microcirculatory Resistance
Description: PIMR measurement involves placing a coronary pressure wire in the pulmonary arteries and making pressure/time measurements during maximal flow down the artery.

Intervention type: OTHER
Intervention: Right Ventricle Index of Microcirculatory Resistance
Description: RV-IMR measurement involves placing a coronary pressure wire in the acute marginal branch of the right coronary artery and making pressure/time measurements during maximal flow down the artery.
Study: NCT06003010

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: 6 yoga videos to be done 2-3x a week for 6 weeks before and after surgery.
Study: NCT05041296

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance scan
Description: Multiparametric cardiac magnetic resonance including traditional and quantitative functional and structural parameters

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance scan
Description: Multiparametric cardiac magnetic resonance including traditional and quantitative functional and structural parameters

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance scan
Description: Multiparametric cardiac magnetic resonance including traditional and quantitative functional and structural parameters
Study: NCT05011864

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation
Description: In BA, depressive symptoms are viewed as depressive behaviors. Compared to those without depression, people with depression engage in fewer overt behaviors that provide positive reinforcement and pleasure/enjoyment and in more behaviors that function to escape or avoid aversive stimuli (e.g., staying in bed all day).55-59 Thus, BA is aimed at increasing and reinforcing meaningful, healthy, and enjoyable behaviors while decreasing depressive behaviors and is well-suited to help depressed, disabled older adults increase mood-enhancing activities, self-care management skills, and social connectedness.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation
Description: In BA, depressive symptoms are viewed as depressive behaviors. Compared to those without depression, people with depression engage in fewer overt behaviors that provide positive reinforcement and pleasure/enjoyment and in more behaviors that function to escape or avoid aversive stimuli (e.g., staying in bed all day).55-59 Thus, BA is aimed at increasing and reinforcing meaningful, healthy, and enjoyable behaviors while decreasing depressive behaviors and is well-suited to help depressed, disabled older adults increase mood-enhancing activities, self-care management skills, and social connectedness.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fall Prevention
Description: Following FP psychoeducation based on the Centers for Disease Control and Prevention (CDC)'s STEADI tool kits, lay coaches will assist clients in implementing evidence-based FP strategies that have been adapted for low-income homebound seniors. These include referrals to healthcare providers as needed, home safety checks, practice of safe ambulation/transfer and mobility aid use, medication review, and in-home exercise routines with an innovative, gamified tablet-based exercise app for balance and strength building.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fall Prevention
Description: Following FP psychoeducation based on the Centers for Disease Control and Prevention (CDC)'s STEADI tool kits, lay coaches will assist clients in implementing evidence-based FP strategies that have been adapted for low-income homebound seniors. These include referrals to healthcare providers as needed, home safety checks, practice of safe ambulation/transfer and mobility aid use, medication review, and in-home exercise routines with an innovative, gamified tablet-based exercise app for balance and strength building.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telephone support
Description: Subjects in this arm will receive 9 weekly support calls last 30 minutes each. These calls are intended to provide an opportunity for social support and check safety.
Study: NCT06177561

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymphoplasma exchange
Description: The LPE treatment regimen is: LPE\*2 times (20-30ml/kg, treatment interval of 2 days);CD20 monoclonal antibody 375mg/m2\*2 times, gamma globulin 0.4g/kg/d\*5d.
Study: NCT04807387

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Stent A
Description: Ring stent

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Stent B
Description: Flower stent

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Stent
Description: Vaginal stent chosen from A or B that is the most comfortable

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Stent
Description: Vaginal stent chosen from A or B that is the most comfortable

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Stent
Description: Vaginal stent chosen from A or B that is the most comfortable
Study: NCT06160830

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: synbiotic
Description: Two capsules of synbiotic per day, each containing 500 mg of synbiotic

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Two capsules of placebo containing maltodextrin per day
Study: NCT05919485

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: 0.06mA/cm2 from each electrode with total density of 0.054/cm2 for 20 minutes for 5 days a week, for 10 days and a total of 10 sessions in 14 days.~Brain area; DLPFC / LPC

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: 0.06mA/cm2 from each electrode with total density of 0.054/cm2 for 20 minutes for 5 days a week, for 10 days and a total of 10 sessions in 14 days.~Brain area; DLPFC / LPC

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: tDCS
Description: 0.06mA/cm2 from each electrode with total density of 0.054/cm2 for 20 minutes for 5 days a week, for 10 days and a total of 10 sessions in 14 days.~Brain area; DLPFC / LPC
Study: NCT05245214

Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Muscle analysis by Magnetic Resonance Imaging

Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Muscle analysis by Magnetic Resonance Imaging